Articles tagged with Breast Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A study published in Radiology found that digital breast tomosynthesis (DBT) with synthetic mammography improved cancer detection rates compared to traditional digital mammography. The technique reduced radiation exposure and detected a higher proportion of early-stage cancers, particularly among women with dense breasts.
A randomized clinical trial demonstrated the reliability of using circulating tumor cell count to guide frontline therapy choice for patients with estrogen receptor-positive (ER+) HER2-negative (HER2) metastatic breast cancer. The CTC count significantly improved progression-free survival for patients with high CTC counts, while hormon...
A new study shows that the introduction of new cancer drugs between 2000 and 2016 led to a significant reduction in mortality rates for patients with 15 common types of cancer, including breast, lung, and colorectal cancer. The study estimates that these drug approvals saved over 1.2 million lives during this period.
Researchers found a significant increase in cancer survival rates among Medicaid expansion states compared to non-expansion states. The study analyzed data from breast, colorectal, and lung cancer patients and discovered improved survival outcomes following the expansion of healthcare coverage.
Researchers found a significant impact on mortality if cancer treatment is delayed, whether it's surgery, chemotherapy, or radiotherapy. A four-week delay in treatment was associated with an increased risk of death across all common forms of cancer treatment.
Researchers found that Trop-2 expression is a predictive biomarker for sacituzumab govitecan efficacy in triple-negative breast cancer. Increasing Trop-2 expression improved SG efficacy in mice with HRR-proficient tumors, suggesting a potential clinical benefit for patients with high Trop-2 levels.
A Mayo Clinic study found that 13.5% of cancer patients had inherited genetic mutations associated with their cancer development. The discovery could lead to targeted cancer therapies and improved survival rates for patients with these high-risk mutations.
Emanuel Petricoin, Co-Director of CAPMM, is receiving $280,696 in funding to discover protein biomarkers for response prediction in stage II/III breast cancer patients. The project aims to utilize data from the ISPY2 TRIAL to develop novel targeted therapy agents.
Nelson will lead a collaborative research team to address shortcomings in breast cancer management, diagnosis, and therapy. He aims to eliminate mortality associated with metastatic breast cancer by leveraging cholesterol homeostasis.
Researchers are exploring glycans in breast cancer cells to develop an earlier test for breast cancer through liquid biopsies. By identifying unique sugar patterns, the team aims to improve diagnostic accuracy and catch cancers at their earliest stage.
A team of researchers discovered that the mammary basal cell lineage contributes to breast cancer heterogeneity, fueling the outgrowth of multiple aggressive tumor subpopulations. By activating a signaling pathway driven by protein kinase A (PKA), they can limit self-renewal potential and impede metastasis.
A new study published in The BMJ provides updated estimates of the increased risks of breast cancer associated with hormone replacement therapy (HRT) use. For longer-term HRT use, the increased risks are lower than previously reported, while a more pronounced decline in risk is observed once HRT has stopped.
A new three-dimensional imaging technique has been developed to improve the visibility of brain tumors in MRI scans, doubling contrast between tumors and normal brain tissue. This could enable earlier detection and more effective treatment of malignant tumors.
A study aims to identify geographic and racial disparities in mammography screening rates among Black and Hispanic women. The research will inform targeted interventions to improve access to screening and reduce mortality from breast cancer.
A new technology makes it possible to analyze all the tissue removed from a tumor in 3D without cutting, significantly increasing the reliability of diagnosis. This revolutionizes pathology and provides new insights into cancer development, potentially leading to improved treatment options.
Researchers at the University of Virginia have discovered that cancer alters the three-dimensional structure of chromosomes to create a comfortable home for itself inside cells. This remodeling is linked to changes in gene expression and can be targeted with specific drugs, offering new approaches to cancer treatment.
A new 'fast' MRI test has been shown to detect breast cancers that 3-D mammograms may miss in women with dense breasts. The test, which is an abbreviated version of traditional breast MRI, detected 27 cancers per 1,000 women screened.
A new technique has found extremely high stiffness in tiny regions of aggressive breast cancer tumors, suggesting only a few areas need to stiffen for metastasis to occur. This could lead to improved cancer detection and mapping.
This issue of Acta Pharmaceutica Sinica B features three original research articles exploring novel mechanisms and treatments for various diseases, including cerebral ischemia-reperfusion injury, anti-atherosclerosis, and breast cancer. The articles discuss the potential benefits of IL-4 supplementation, berberine's gut-absorption-enha...
A collaborative team developed an organs-on-a-chip system to monitor heart toxicity from breast cancer drugs. The dual-organ system closely mimics bodily tissues and provides evidence that the interplay between the heart and breast cancer tissues influences cell function and disease progression.
A new study reveals that women over 65 with breast cancer have a significant risk of developing the disease due to disease-causing mutations in predisposition genes. The researchers found that up to 20% of these women may still be at high risk for breast cancer, even without prior diagnosis.
Research suggests that genetic predisposition to increased weight is causally protective for breast and prostate cancer. Heavier women are less likely to develop breast cancer due to additional differences between groups, while heavier men are less likely to develop prostate cancer, particularly when exposed to carcinogenic substances.
Researchers found that Indian and Pakistani women are diagnosed with breast cancer at a younger age and at more advanced stages than non-Hispanic white women. The study highlights the need for culturally relevant strategies to improve preventive healthcare in this growing population.
Researchers have identified certain features of a patient's tumor that can predict whether axillary lymph node dissection is necessary, sparing women from disabling arm swelling. A UCLA study found over 40% of women with lymph node involvement at diagnosis have only 1-3 positive nodes at surgery.
Researchers at Texas A&M University developed a method to detect and monitor pediatric brain cancer using epigenetic markers in cerebrospinal fluid. The approach, which overcomes limitations of liquid biopsy, holds promise for giving clinicians real-time insights into treatment response.
Research found that vitamin D3 reduces both HAS2 gene expression and hyaluronic acid synthesis in multiple models of breast cancer. The study suggests a novel role for vitamin D3 and the VDR in control of HA synthesis, which likely contributes to its anti-cancer actions.
A new study suggests that controlling two proteins, ANP32E and H2AZ, could prevent cancer by regulating cell division and tumor growth. With high levels of H2AZ found in breast and brain cancers, targeting these proteins may make cancer cells more sensitive to anti-cancer drugs or immune-system attack.
Researchers found that combining Th1 cytokines IFN-gamma and TNF-alpha with the small molecule Akt antagonist MK-2206 maximizes indicators of apoptotic cell death in breast cancer cells. The study also suggests a combined therapy approach for Akt-targeting drugs that incorporates recombinant Interferon-gamma.
Researchers discovered a new combination of treatments that may benefit patients with certain gene mutations. Inhibiting the protein AKT suppressed growth of tumour cells in animal models, while combining dexamethasone with AKT inhibition showed better results.
Researchers at Moffitt Cancer Center discovered specific molecules, TAp63, long noncoding RNA (lncRNA), and proteins WDR26 and NOLC1 that regulate AKT signaling pathway to promote tumor development and progression.
Research suggests that performing physical activity in the morning can significantly reduce breast and prostate cancer risk. The study found that exercising between 8-10 am had the strongest protective effect, particularly for individuals with late chronotypes.
Michigan State University researchers are developing a precision nanotherapy that turns the body's own cells into weapons against breast cancer. The approach targets cancer cells' CD47 protein, which defends against immune cells, and uses ultra-thin carbon tubes to arm immune cells for a covert attack.
Researchers at CNIO successfully applied CRISPR technology to eliminate fusion genes causing tumors, leading to the death of cancer cells while leaving healthy cells unaffected. This breakthrough approach could lead to the development of targeted cancer therapies.
A new digital dashboard, NAVIFY Tumor Board, has been shown to significantly reduce the time spent preparing for cancer treatment cases by 30%, while also improving access to relevant clinical data. The study found that this improvement was sustained over time and resulted in reduced administrative burdens for healthcare professionals.
Researchers have developed a new hyperpolarisation technique to monitor cancer drug efficacy, potentially replacing tissue biopsies. The method detects biomarkers like FOXM1, indicating drug resistance in ER-positive breast cancer.
A recent study published in the American College of Surgeons found that over 80% of young women can successfully breastfeed or bottle-feed after undergoing surgery for benign breast conditions. The research aimed to address concerns among breast surgeons and pediatricians about the impact of surgery on future breastfeeding capability.
Spanish-speaking women are less likely to receive screening mammograms due to language barriers. Women with limited English proficiency had 27% lower rates of mammogram screenings, according to the study. This disparity affects approximately 450,000 eligible women in the US.
Researchers found that minority-serving hospitals offer a strong level of evidence-based care for early-stage breast cancer, with similar rates of following recommended surgical procedures as non-minority hospitals. However, disparities exist in access to high-quality care and adherence to treatment guidelines among minority-serving ho...
Research at the European Breast Cancer Conference highlights a significant difference in survival rates between breast cancers detected during screening and those detected in the interval between screenings. Screen-detected cancers have higher eight-year distant metastasis-free interval rates, even among high-risk tumours.
A study by Spanish researchers found that women with incident, proliferative benign breast disease are at a nearly four-fold increased risk of developing breast cancer compared to those with no BBD. The study analyzed data from over 629,000 women and recommends personalized screening strategies based on individual risk factors.
The NeoALTTO BIG-06 trial found that women who achieved pathological complete response (pCR) after treatment had better long-term survival without cancer recurrence. Patients receiving both lapatinib and trastuzumab in combination also had a higher rate of pCR, resulting in improved overall survival rates.
Researchers used computer analysis of CT scans to identify women at high risk of cardiovascular disease, with those having the highest CAC score showing a 3.7 times greater risk. The study showed that treating breast cancer means finding a balance between tackling tumors and minimizing side effects, including cardiovascular disease.
Researchers are exploring how patterns of collagens serve as biomarkers for breast cancer risk and progression, with a focus on addressing health disparities. A $3 million grant is supporting the study, led by Dr. Peggi Angel at the Medical University of South Carolina.
A new study suggests that the pandemic may lead to an increase in breast cancer deaths, but delaying or increasing capacity can lower this risk. Increasing staff and equipment would be needed for a full catch-up, but a temporary age limit raise or re-starting as normal with final screenings could be effective alternatives.
Breast and lung cancer cells use the Slit2 protein, normally produced by neurons, to signal their migration. This intricate mechanism enables them to escape primary tumors and spread to other organs. The findings could lead to novel diagnostics and treatments for metastasis.
A new genetic test identifies patients with invasive lobular carcinoma (ILC) at high risk of recurring and progressing. The 70-gene signature test showed that ILC patients whose genetic make-up puts them at high risk may benefit from additional adjuvant therapy.
A new study published in Frontiers In Oncology found a negative association between beta-blocker use and survival outcomes in patients with HER2 positive advanced breast cancer. The research highlights a subgroup of patients whose survival outcomes are poorer and calls for further investigation to improve treatment outcomes.
A new CDK 4/6 inhibitor, abemaciclib, has been shown to reduce the risk of breast cancer recurrence in high-risk patients with hormone receptor-positive (HR+) early-stage disease by 25%. The monarchE study found that adding abemaciclib to standard hormone therapy significantly improved patient outcomes.
A recent study shows that most older women with breast cancer can safely undergo surgery, reducing the gap in survival rates between older and younger women. The research found that surgery is generally well-tolerated and offers slightly lower survival rates for those who don't have it.
A recent study found that COVID-19-related interruptions in rehabilitation care for women with breast cancer led to increased emotional distress and reduced physical activity. The study, published in Rehabilitation Oncology, surveyed 15 breast cancer survivors who experienced cancelled appointments due to the pandemic.
A new study reveals that surgical treatment of breast asymmetry in young women yields significant and sustained improvements in psychosocial quality of life. The procedure corrected severe breast asymmetry, averaging two cup sizes difference between breasts, and led to notable enhancements in self-esteem, social functioning, and emotio...
Researchers at Lund University developed a computational model to detect and identify genetic mutations in breast tumours using RNA sequencing. The study found that almost 87% of patients had at least one mutation for which potential drugs exist, with specific genes like PIK3CA associated with good prognosis.
A computational pipeline predicts tumour response to different cancer treatments by identifying complex response markers from the patterns of co-occurrence between cancer driver genes. The system achieved 66% accuracy in predicting responses, offering a key factor in precision medicine for patients.
Scientists at UT Austin identified a protein that promotes DNA damage in BRCA 1/2-mutated cancer cells, making them resistant to PARP inhibitors. The finding may help create more effective treatment plans for patients with these cancers.
A new method for identifying sentinel lymph nodes (SLNs) in breast cancer uses photoacoustic microscopy and CD44 and SR-B1 dual-targeting nanoparticles. The technique distinguishes between metastatic SLNs and inflamed LNs, providing a potential solution for reducing complications during surgery.
A new study published in Cancer found that Black women experience longer waits for treatment initiation and prolonged duration of treatment after a breast cancer diagnosis. The research, which analyzed data from over 2,800 participants, identified financial and transportation issues as key contributors to these delays.
A recent study published in the journal Cancer found that Black women with breast cancer experience delays in starting treatment and have extended durations of treatment compared to white women. The study, led by UNC Lineberger Comprehensive Cancer Center researchers, also identified socioeconomic status as a significant factor influen...
The PROfound trial demonstrates the efficacy of PARP inhibitor olaparib in treating metastatic castration-resistant prostate cancer (mCRPC) with at least one alteration in BRCA1 or BRCA2 genes. Olaparib significantly improves overall survival, particularly in patients with alterations in these genes.
A study at ESMO 2020 found that adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive breast cancer. This new treatment approach improves invasive disease free survival and may spare chemotherapy in this group of patients.
Researchers found that asymptomatic breast cancer patients with brain metastases had fewer and smaller tumors, received less aggressive treatment, and lived longer than those who developed symptoms. The study suggests that early detection of brain metastases could improve survival rates for these patients.